Skip to main content
SpringerLink
Log in

Vasopressine et analogues

  • Chapter
Sepsis sévère et choc septique

Part of the book series: Le point sur⋯ ((POINT))

  • 338 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Landry DW, Levin HR, Gallant EM et al. (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25: 1279–82

    CAS  PubMed  Google Scholar 

  2. Okamura T, Toda M, Ayajiki K, Toda N (1997) Receptor subtypes involved in relaxation and contraction by arginine vasopressin in canine isolated short posterior ciliary arteries. J Vasc Res 34: 464–72

    CAS  PubMed  Google Scholar 

  3. Landry DW, Levin H, Gallant E et al. (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95: 1122–5

    CAS  PubMed  Google Scholar 

  4. Gold J, Cullinane S, Chen J et al. (2000) Vasopressin in the treatment of milrinone induced hypotension in severe heart failure. Am J Cardiol 85: 506–88, A11

    CAS  PubMed  Google Scholar 

  5. Laszlo FA, Laszlo F Jr, De Wield D (1991) Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev 43: 73–108

    CAS  PubMed  Google Scholar 

  6. Forrest P (2001) Vasopressin and shock. Anaesth Intensive Care 29(5): 463–72

    CAS  PubMed  Google Scholar 

  7. Krismer AC, Wenzel V, Mayr VD et al. (2001) Arginine vasopressin during cardiopulmonary resuscitation and vasodilatory shock: current experience and future perspectives. Curr opin in Crit Care 7: 157–69

    CAS  Google Scholar 

  8. Holmes CL, Patel BM, Russell JA (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120,3: 989–99

    Article  CAS  PubMed  Google Scholar 

  9. Malay MB, Ashton RC Jr, Landry DW, Townsend RN (1999) Low dose of vasopressin in the treatment of vasodilatory septic shock. J Trauma 47: 699–703

    CAS  PubMed  Google Scholar 

  10. Argenziano M, Chen JM, Choudhri AF et al. (1998) Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. Thorac Cardiovasc Surg 116: 973–80

    CAS  Google Scholar 

  11. Argenziano M, Choudhri AF, Oz MC et al. (1997) A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 96: 286–90

    CAS  Google Scholar 

  12. Argenziano M, Chen JM, Cullinane S et al. (1999) Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. J Heart Transplant 18: 814–7

    CAS  Google Scholar 

  13. Morales DL, Gregg D, Helman DN et al. (2000) Arginine vasopressin in the treatment of 50 patients with post cardiotomy vasodilatory shock. Ann Thorac Surg 69: 102–6

    Article  CAS  PubMed  Google Scholar 

  14. Chen JM, Cullinane S, Spanier TB et al. (1999) Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 100: II-244–6

    CAS  Google Scholar 

  15. Tsuneyoshi I, Yamada H, Kakihana Y et al. (2001) 3rd Hemodynamic and metabolic effects of low dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29,3: 487–93

    CAS  PubMed  Google Scholar 

  16. Holmes CL, Walley KR, Chittock DR et al. (2001) The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27: 1416–21

    Article  CAS  PubMed  Google Scholar 

  17. Dünser M, Luckner G, Mayr A et al. (2000) Hemodynamic changes during continuous infusion of vasopressin in critically ill patients with severe MODS. Intensive Care Med [résumé] 26,3: S219

    Google Scholar 

  18. Lauzier F, Berard D, Lamarre P et al. (2002) Vasopressine contre noradrenaline dans la prise en charge initiale du choc septique: analyse intermédiaire d’ une étude clinique randomisée. Reanim Urg [résumé] 10(Suppl. 1): 53s–4s

    Google Scholar 

  19. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96: 576–82

    Article  CAS  PubMed  Google Scholar 

  20. Nicolet-Barousse L, Sharshar T, Paillard M, Blanchard A (2001) La vasopressine: une hormone aux multiples fonctions. Médecine thérapeutique-Endocrinologie 7: 757–64

    Google Scholar 

  21. Prengel AW, Lindner KH, Ensinger H, Grunert A (1992) Plasma catecholamine concentrations after successful resuscitation in patients. Crit Care Med 20: 609–14

    CAS  PubMed  Google Scholar 

  22. Lindner KH, Strohmenger HU, Prengel AW et al. (1992) Hemodynamic and metabolic effects of epinephrine during cardiopulmonary resuscitation in a pig model. Crit Care Med 20: 1020–6

    CAS  PubMed  Google Scholar 

  23. Schultz CH, Rivers EP, Feldcamps CS et al. (1993) A characterization of hypothalamicpituitaryadrenal axis function during and after human cardiac arrest. Crit Care Med 21: 1339–47

    CAS  PubMed  Google Scholar 

  24. Lindner KH, Strohmenger HU, Ensinger H et al. (1992) Stress hormone response during and after CPR. Anesthesiology 77: 662–8

    CAS  PubMed  Google Scholar 

  25. Lindner KH, Haak T, Keller A et al. (1996) Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 75: 145–50

    CAS  PubMed  Google Scholar 

  26. Schwartz J, Reid IA (1983) Role of vasopressin in blood pressure regulation in conscious water-deprived dogs. Am J Physiol 244: R74–7

    CAS  PubMed  Google Scholar 

  27. American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1658–62

    Google Scholar 

  28. Ruokonen G, Takala J, Kari Y, Alhava E (1991) Septic shock and multi organ failure. Crit Care Med 19: 1146–51

    CAS  PubMed  Google Scholar 

  29. Parrillo JE, Parker MM, Natanson C et al. (1990) Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113: 227–42

    CAS  PubMed  Google Scholar 

  30. Martin C, Eon B, Saux P et al. (1990) Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18: 282–5

    Google Scholar 

  31. Fukuoka T, Nishimura N, Imanaka H et al. (1989) Effects of norepinephrine on renal function in septic patients with normal or elevated serum lactate levels. Crit Care Med 17: 1104–7

    CAS  PubMed  Google Scholar 

  32. Martin C, Papazian L, Perrin G et al. (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 103: 1826–31

    CAS  PubMed  Google Scholar 

  33. Ruokonen E, Takala J, Kari A et al. (1993) Regional blood flow and oxygen transport in septic shock. Crit Care Med 21: 1296–303

    CAS  PubMed  Google Scholar 

  34. Van Haren FMP, Rozendaal FW, Van der Hoeven JG (2003) The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124, 2256–60

    PubMed  Google Scholar 

  35. Dünser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 107, 2313–9

    PubMed  Google Scholar 

  36. Bracco D et al. (2001) ESICM, 14th Annual Congress. Abstract no 15.

    Google Scholar 

  37. Sladen RN et al. (2002) ASA meeting. Anesthesiology 96, A349

    Google Scholar 

  38. O’Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359: 1209–10

    CAS  PubMed  Google Scholar 

  39. Léone M, Albanese J, Delmas A et al. (2004) Terlipressine in catecholamine-resistant septic shock patients. Shock 22, 314–9

    PubMed  Google Scholar 

  40. Morelli A, Rocco M, Conti G et al. (2004) Effects of terlipressin on gastric mucosa in catecholamine-dependent septic shock. Intensive Care Med 30, 597–604

    Article  PubMed  Google Scholar 

  41. Westphal M Stubbe H, Sielenkämper AW et al. (2003) Terlipressin response in healthy and endotoxinemic sheep: impact on cardiopulonary performance and global oxygen. Intensive Care Med 29, 301–8

    PubMed  Google Scholar 

  42. Rodriguez-Numez A, Fernandez-Sanmartin M, Martinon-Torres F et al. (2004) Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 30, 477–80

    Google Scholar 

Download references

Authors
  1. A. Delmas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Garnier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag France

About this chapter

Cite this chapter

Delmas, A., Garnier, F., Martin, C. (2005). Vasopressine et analogues. In: Sepsis sévère et choc septique. Le point sur⋯. Springer, Paris. https://doi.org/10.1007/2-287-27496-0_15

Download citation

  • DOI: https://doi.org/10.1007/2-287-27496-0_15

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-22072-2

  • Online ISBN: 978-2-287-27496-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation